All In Biotech

Drug Trial Radar · NCT01628549

Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris

A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Different Doses of a Novel Tetracycline Compared to Placebo in the Treatment of Facial Acne Vulgaris, Study PR-10411

Last checked: Nov 20, 2026Latest source record: Feb 1, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 285 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

285

Actual

Start

Jun 30, 2012

Primary completion

Nov 16, 2012

Study completion Jan 31, 2013

Sponsor

Lead sponsor
Almirall, S.A.Industry
Sponsor type
Industry
Collaborators
Allergan
First posted
Jun 26, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 12 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and effectiveness of 3 strengths of P005672-HCl compared to placebo for the treatment of moderate to severe facial acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • 50 mg P005672-HClDrug

    P005672-HCl administered as an oral capsule(s) once daily

  • PlaceboDrug

    Dose-matched Placebo capsule administered as an oral capsule(s) once daily

  • 100 mg P005672-HClDrug

    P005672-HCl administered as an oral capsule(s) once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Absolute Change From Baseline in the Inflammatory Lesion Count at the Final VisitTime frame: Baseline (Week 0) to Final Visit (Up to Week 12)
  2. The Dichotomized IGA (Investigator Global Assessment) Score at Final VisitTime frame: Final Visit (Up to Week 12)

Locations

38 sites in 1 country. Site status is shown where the registry gives one.

  • Warner Chilcott Investigational Site

    Mobile, Alabama

  • Warner Chilcott Investigational Site

    Tucson, Arizona

  • Warner Chilcott Investigational Site

    Hot Springs, Arkansas

  • Warner Chilcott Investigational Site

    Los Angeles, California

  • Warner Chilcott Investigational Site

    San Diego, California

  • Warner Chilcott Investigational Site

    Santa Monica, California

  • Warner Chilcott Investigational Site

    Clearwater, Florida

  • Warner Chilcott Investigational Site

    Coral Gables, Florida

  • Warner Chilcott Investigational Site

    Gainesville, Florida

  • Warner Chilcott Investigational Site

    Miami, Florida

  • Warner Chilcott Investigational Site

    Miramar, Florida

  • Warner Chilcott Investigational Site

    Pinellas Park, Florida

  • Warner Chilcott Investigational Site

    Arlington Heights, Illinois

  • Warner Chilcott Investigational Site

    Chicago, Illinois

  • Warner Chilcott Investigational Site

    Granger, Indiana

  • Warner Chilcott Investigational Site

    Indianapolis, Indiana

  • Warner Chilcott Investigational Site

    Louisville, Kentucky

  • Warner Chilcott Investigational Site

    Boston, Massachusetts

  • Warner Chilcott Investigational Site

    Fridley, Minnesota

  • Warner Chilcott Investigational Site

    St Louis, Missouri

  • Warner Chilcott Investigational Site

    Berlin, New Jersey

  • Warner Chilcott Investigational Site

    Albuquerque, New Mexico

  • Warner Chilcott Investigational Site

    Rochester, New York

  • Warner Chilcott Investigational Site

    Rochester, New York

  • Warner Chilcott Investigational Site

    Charlotte, North Carolina

  • Warner Chilcott Investigational Site

    Salisbury, North Carolina

  • Warner Chilcott Investigational Site

    Wilmington, North Carolina

  • Warner Chilcott Investigational Site

    Cincinnati, Ohio

  • Warner Chilcott Investigational Site

    Portland, Oregon

  • Warner Chilcott Investigational Site

    Philadelphia, Pennsylvania

  • Warner Chilcott Investigational Site

    Greer, South Carolina

  • Warner Chilcott Investigational Site

    Arlington, Texas

  • Warner Chilcott Investigational Site

    Austin, Texas

  • Warner Chilcott Investigational Site

    Houston, Texas

  • Warner Chilcott Investigational Site

    Plano, Texas

  • Warner Chilcott Investigational Site

    San Antonio, Texas

  • Warner Chilcott Investigational Site

    Sandy City, Utah

  • Warner Chilcott Investigational Site

    Lynchburg, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.